These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30762284)

  • 21. Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?
    Hankey GJ
    Stroke; 2002 Jun; 33(6):1723-6. PubMed ID: 12053018
    [No Abstract]   [Full Text] [Related]  

  • 22. Warfarin or aspirin for recurrent ischemic stroke.
    Hsi DH; Alaimo DJ
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11951855
    [No Abstract]   [Full Text] [Related]  

  • 23. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome.
    Derksen RH; de Groot PG; Kappelle LJ
    Neurology; 2003 Jul; 61(1):111-4. PubMed ID: 12847169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
    Overgaard K; Poulsen TS; Husted SE
    Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory effect on platelet activity within 24 h of the first 300-mg oral dose of aspirin given in hospital during the acute phase of ischemic cerebral events.
    Richard S; Toussaint-Hacquard M; Fay R; Lacour JC; Ducrocq X; Lecompte T
    Cerebrovasc Dis; 2012; 33(6):574-8. PubMed ID: 22710855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triflusal and aspirin in the secondary prevention of atherothrombotic ischemic stroke: a very long-term follow-up.
    Alvarez-Sabín J; Quintana M; Santamarina E; Maisterra O
    Cerebrovasc Dis; 2014; 37(3):181-7. PubMed ID: 24503927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin resistant patients with recent ischemic stroke.
    Castilla-Guerra L; Navas-Alcántara MS; Fernández-Moreno MC
    Rev Clin Esp (Barc); 2014 Apr; 214(3):145-9. PubMed ID: 24211052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Significance of Acute and Serial Platelet Function Testing in Acute Ischemic Stroke.
    Kim JT; Choi KH; Park MS; Lee JS; Saver JL; Cho KH
    J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Warfarin or aspirin for recurrent ischemic stroke.
    Lewis SC; Sandercock PA
    N Engl J Med; 2002 Apr; 346(15):1169-71. PubMed ID: 11948280
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.
    Shrestha S; Coy S; Bekelis K
    Curr Pharm Des; 2017; 23(9):1377-1391. PubMed ID: 28003013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet therapy in the prevention of ischaemic stroke.
    Verry M; Panak E; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1994 Jun; 36(3):213-28. PubMed ID: 7971242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choices in medical management for prevention of acute ischemic stroke.
    Fleck JD; Biller J
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):33-8. PubMed ID: 11898498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights in antiplatelet therapy for patients with ischemic stroke.
    Chaturvedi S; Bhattacharya P
    Neurologist; 2011 Sep; 17(5):255-62. PubMed ID: 21881467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel.
    Cha JK; Jeong MH; Lee KM; Bae HR; Lim YJ; Park KW; Cheon SM
    J Thromb Thrombolysis; 2002 Oct; 14(2):145-50. PubMed ID: 12714834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of platelet aggregation during antiplatelet therapy in ischemic stroke.
    Pongrácz E
    Clin Hemorheol Microcirc; 2004; 30(3-4):237-42. PubMed ID: 15258349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.